Product Information

CARVEDILOL 12.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0209 per EA under NDC 65862014401. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL 12.5 MG TABLET

Carvedilol
$0.0209per EA

Strength

12.5 mg/1

NDC

65862014401

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CARVEDILOL

Approval Type

Generic (ANDA)

FDA Application

ANDA078332

FDA Approved

9/5/2007

TE Code

AB

On Market Since

9/5/2007

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL 12.5 MG TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0209 per EA
All-time high$0.0359 (Dec 16, 2015)
All-time low$0.0184 (Nov 20, 2024)
52-week high$0.0216
52-week low$0.0209
Median price$0.0250
Average price$0.0259
Largest weekly change+19.9% (Nov 18, 2015)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

-1.8%

1M

-3.3%

3M

-2.3%

6M

-0.7%

1Y

-3.3%

3Y

-8.7%

5Y

-14.8%

All

-36.7%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CARVEDILOL 12.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 12.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0209 per EA (NDC 65862014401), effective Nov 18, 2026.

How has the price of CARVEDILOL 12.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARVEDILOL 12.5 MG TABLET has declined 36.7%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CARVEDILOL 12.5 MG TABLET?

Since Nov 28, 2013, the NADAC for CARVEDILOL 12.5 MG TABLET has ranged from a low of $0.0184 (Nov 20, 2024) to a high of $0.0359 (Dec 16, 2015), with a median of $0.0250 per EA.

Are there cheaper alternatives to CARVEDILOL 12.5 MG TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL 12.5 MG TABLET?

CARVEDILOL 12.5 MG TABLET (NDC 65862014401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.